Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions

NCT03093818 is registered in ClinicalTrials.gov with J.J.Swen as lead sponsor.

NCT NCT03093818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03093818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
Lead sponsor
J.J.Swen
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2017
Completion date
May 1, 2021
Enrollment
6,950 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reaction